HEALTHJanuary 1, 2025Article
HER2-Mutant Lung Adenocarcinoma with Concurrent TP53 Mutation — Cross-Border Expert Evaluation to Clarify Subsequent Treatment Pathway
Full article text is not available for this entry.
Full article text is not available for this entry.